| Autor: |
Pansarasa O; IRCCS Mondino Foundation, 27100 Pavia, Italy., Garofalo M; IRCCS Mondino Foundation, 27100 Pavia, Italy., Scarian E; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Brain and Behavioral Sciences, University of Pavia, Via Forlanini 6, 27100 Pavia, Italy., Dragoni F; IRCCS Mondino Foundation, 27100 Pavia, Italy.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, 27100 Pavia, Italy., Garau J; IRCCS Mondino Foundation, 27100 Pavia, Italy., Di Gerlando R; IRCCS Mondino Foundation, 27100 Pavia, Italy., Diamanti L; IRCCS Mondino Foundation, 27100 Pavia, Italy., Bordoni M; IRCCS Mondino Foundation, 27100 Pavia, Italy., Gagliardi S; IRCCS Mondino Foundation, 27100 Pavia, Italy. |
| Abstrakt: |
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by the progressive loss of lower motor neurons, weakness and muscle atrophy. ALS lacks an effective cure and diagnosis is often made by exclusion. Thus, it is imperative to search for biomarkers. Biomarkers can help in understanding ALS pathomechanisms, identification of targets for treatment and development of effective therapies. Peripheral blood mononuclear cells (PBMCs) represent a valid source for biomarkers compared to cerebrospinal fluid, as they are simple to collect, and to plasma, because of the possibility of detecting lower expressed proteins. They are a reliable model for patients' stratification. This review provides an overview on PBMCs as a potential source of biomarkers in ALS. We focused on altered RNA metabolism (coding/non-coding RNA), including RNA processing, mRNA stabilization, transport and translation regulation. We addressed protein abnormalities (aggregation, misfolding and modifications); specifically, we highlighted that SOD1 appears to be the most characterizing protein in ALS. Finally, we emphasized the correlation between biological parameters and disease phenotypes, as regards prognosis, severity and clinical features. In conclusion, even though further studies are needed to standardize the use of PBMCs as a tool for biomarker investigation, they represent a promising approach in ALS research. |
